| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |